Literature DB >> 19733709

Comparison of blood glucose values on admission for acute myocardial infarction in patients with versus without diabetes mellitus.

Masaharu Ishihara1, Sunao Kojima, Tomohiro Sakamoto, Kazuo Kimura, Masami Kosuge, Yujiro Asada, Chuwa Tei, Shunichi Miyazaki, Masahiro Sonoda, Kazufumi Tsuchihashi, Masakazu Yamagishi, Mutsunori Shirai, Hisatoyo Hiraoka, Takashi Honda, Yasuhiro Ogata, Hisao Ogawa.   

Abstract

Previous studies have reported that acute hyperglycemia is associated with high mortality after acute myocardial infarction (AMI). However, optimal plasma glucose level may be different between diabetic and nondiabetic patients. The purpose of this study was to assess the relation between admission glucose and in-hospital mortality after AMI in patients with and without diabetes. This study consisted of 3,750 patients who were admitted to the 35 hospitals participating to the Japanese Acute Coronary Syndrome Study (JACSS) group within 48 hours after the onset of AMI. Plasma glucose was measured at the time of hospital admission. In patients without a history of diabetes, there was a linear relation between admission glucose and in-hospital mortality. Nondiabetic patients with a glucose level <6 mmol/L had the lowest mortality (2.5%). As admission glucose increased by 1 mmol/L, mortality increased by 17% (13% to 21%, p <0.001). In patients with a history of diabetes, however, there was a U-shape relation between glucose and mortality. Diabetic patients with glucose 9 to 10 mmol/L had the lowest mortality (1.9%); not only severe hyperglycemia (glucose > or =11 mmol/L, 9.1%, p <0.001) but also euglycemia (glucose <7 mmol/L, 9.4%, p = 0.009) were associated with higher mortality compared to moderate hyperglycemia (glucose 9 to 11 mmol/L, 3.2%). Diabetic patients with admission glucose 9 to 10 mmol/L had the lowest mortality, whereas lower glucose was better in nondiabetic patients. In conclusion, optimal glucose level on admission may be different between diabetic and nondiabetic patients with AMI.

Entities:  

Mesh:

Year:  2009        PMID: 19733709     DOI: 10.1016/j.amjcard.2009.04.055

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  15 in total

1.  Effect of abnormal fasting plasma glucose level on all-cause mortality in older patients with acute myocardial infarction: results from the Beijing Elderly Acute Myocardial Infarction Study (BEAMIS).

Authors:  Shi-Wei Yang; Yu-Jie Zhou; Xiao-Min Nie; Yu-Yang Liu; Jie Du; Da-Yi Hu; De-An Jia; Fei Gao; Bin Hu; Zhe Fang; Hong-Ya Han; Xiao-Li Liu; Zhen-Xian Yan; Jian-Long Wang; Qi Hua; Yu-Jie Shi; Hong-Wei Li
Journal:  Mayo Clin Proc       Date:  2011-02       Impact factor: 7.616

2.  Acute hyperglycemia causes microvascular damage, leading to poor functional recovery and remodeling in patients with reperfused ST-segment elevation myocardial infarction.

Authors:  Katsuhiko Sarazawa; Akira Nakano; Hiroyasu Uzui; Yasuhiko Mitsuke; Tohru Geshi; Hidehiko Okazawa; Takanori Ueda; Jong-Dae Lee
Journal:  J Nucl Cardiol       Date:  2012-06       Impact factor: 5.952

3.  Interaction of β1-adrenoceptor with RAGE mediates cardiomyopathy via CaMKII signaling.

Authors:  Weizhong Zhu; Sharon Tsang; David M Browe; Anthony Yh Woo; Ying Huang; Chanjuan Xu; Jian-Feng Liu; Fengxiang Lv; Yan Zhang; Rui-Ping Xiao
Journal:  JCI Insight       Date:  2016

4.  Admission glucose and left ventricular systolic function in non-diabetic patients with acute myocardial infarction.

Authors:  Joanna Gierach; Marcin Gierach; Iwona Świątkiewicz; Marek Woźnicki; Grzegorz Grześk; Adam Sukiennik; Marek Koziñski; Jacek Kubica
Journal:  Heart Vessels       Date:  2014-12-25       Impact factor: 2.037

5.  The effect of glycaemic control and glycaemic variability on mortality in patients hospitalized with congestive heart failure.

Authors:  Kathleen M Dungan; Philip Binkley; Haikady N Nagaraja; Dara Schuster; Kwame Osei
Journal:  Diabetes Metab Res Rev       Date:  2011-01       Impact factor: 4.876

6.  Glycemic Control in Coronary Revascularization.

Authors:  Francisco Ujueta; Ephraim N Weiss; Steven P Sedlis; Binita Shah
Journal:  Curr Treat Options Cardiovasc Med       Date:  2016-02

Review 7.  Hypoglycemia and cardiovascular risks.

Authors:  Brian M Frier; Guntram Schernthaner; Simon R Heller
Journal:  Diabetes Care       Date:  2011-05       Impact factor: 19.112

8.  Relationship between admitting nonfasting blood glucose and in-hospital mortality stratified by diabetes mellitus among acute coronary syndrome patients in oman.

Authors:  Prashanth Panduranga; Kadhim Sulaiman; Jawad Al-Lawati; Ibrahim Al-Zakwani
Journal:  Heart Views       Date:  2011-01

9.  Association Between Fasting Hyperglycemia and New-Onset Atrial Fibrillation in Patients With Acute Myocardial Infarction and the Impact on Short- and Long-Term Prognosis.

Authors:  Mingxing Li; Yingying Gao; Kai Guo; Zidi Wu; Yi Lao; Jiewen Li; Xuansheng Huang; Li Feng; Jianting Dong; Yong Yuan
Journal:  Front Cardiovasc Med       Date:  2021-07-01

10.  Analysis of factors related to short-term prognosis in patients undergoing percutaneous coronary intervention for acute myocardial infarction.

Authors:  Yi Ma; Li Li; Xiao-Ming Shang; Zheng Tan; Xue-Bin Geng; Bi-Qiong Zhao; Mei-Rong Tian
Journal:  Exp Ther Med       Date:  2013-01-25       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.